Researchers sought to describe the practice patterns of NPs and PAs, understand the barriers these providers face in providing buprenorphine treatment, and compare them with their physician counterparts and across varying levels of practice autonomy.
Overall, of 333 adult patients, 15.9% of patients reported opioid misuse, 17.1% were positive for PTSD, and 52.6% were positive for depression.
Treatment with either teriparatide or percutaneous vertebroplasty significantly and similarly improved quality of life and reduced pain in patients with acute osteoporotic vertebral compression fractures.
Findings confirm that high painDETECT scores can be found in nearly all musculoskeletal conditions, are associated with much longer duration of daily pain, and can occur early after the onset of the current pain episode, but may not worsen over time.
Prescription opioid use among teens and young adults is higher than expected, with most obtaining the drugs from friends and family.
Despite a decline in the number of opioid prescriptions issued by surgeons, patient-reported satisfaction scores have remained constant.
The ever-increasing range of cannabis products on the market has been accompanied by varying levels of ∆9-tetrahydrocannabinol (THC) and cannabidiol (CBD) and may confer increased risks for THC-related harm.
The adjusted rate of opioid use increased nearly 4-fold (adjusted odds ratio, 4.18; 95% CI, 1.76-9.96), from 4.7% among new immigrants to 14.8% among those who had been in this country for 15 years or more.
Clinicians are routinely asked by their patients if CBD products are safe and effective, but research is lagging behind public acceptance.
Though gastroenterologists are prescribing fewer opioids for Medicare patients, they should also prescribe more neuromodulators because there is more high-quality evidence supporting their efficacy for conditions causing chronic abdominal pain conditions.